Abstract
Mycoplasma genitalium is characterized by a small genome and a lack of a cell wall, contributing to its unique biology. It is associated with reproductive tract infections, including non-gonococcal urethritis and pelvic inflammatory disease. It is nearly as common as chlamydia in most studies from high-income countries. The emergence of antimicrobial resistance in M. genitalium raises concern about the long-term efficacy of current therapeutic strategies. Understanding its genomic intricacies and pathogenic mechanisms is crucial for developing targeted interventions to address the growing public health impact of this elusive microbe.
| Original language | English |
|---|---|
| Article number | 001984 |
| Journal | Journal of Medical Microbiology |
| Volume | 74 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 4 Apr 2025 |
Keywords
- fluoroquinolones
- macrolide resistance
- non-gonococcal urethritis
- Genome, Bacterial
- Humans
- Reproductive Tract Infections - microbiology - epidemiology
- Urethritis - microbiology
- Drug Resistance, Bacterial
- Mycoplasma genitalium - genetics - pathogenicity - drug effects - physiology
- Mycoplasma Infections - microbiology - epidemiology - drug therapy
- Anti-Bacterial Agents - pharmacology - therapeutic use
- Female
- Pelvic Inflammatory Disease - microbiology